Sunshine Biopharma Warrant Stock Probability of Future Stock Price Finishing Under 0.12
| SBFMW Stock | USD 0.21 0.01 4.55% |
Sunshine |
Sunshine Biopharma Target Price Odds to finish below 0.12
The tendency of Sunshine Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 0.12 or more in 90 days |
| 0.21 | 90 days | 0.12 | about 49.92 |
Based on a normal probability distribution, the odds of Sunshine Biopharma to drop to $ 0.12 or more in 90 days from now is about 49.92 (This Sunshine Biopharma Warrant probability density function shows the probability of Sunshine Stock to fall within a particular range of prices over 90 days) . Probability of Sunshine Biopharma price to stay between $ 0.12 and its current price of $0.21 at the end of the 90-day period is about 49.0 .
Assuming the 90 days horizon Sunshine Biopharma Warrant has a beta of -2.01. This usually implies as returns on its benchmark rise, returns on holding Sunshine Biopharma Warrant are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Sunshine Biopharma is expected to outperform its benchmark. In addition to that Sunshine Biopharma Warrant has an alpha of 4.11, implying that it can generate a 4.11 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Sunshine Biopharma Price Density |
| Price |
Predictive Modules for Sunshine Biopharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sunshine Biopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sunshine Biopharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Sunshine Biopharma is not an exception. The market had few large corrections towards the Sunshine Biopharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Sunshine Biopharma Warrant, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Sunshine Biopharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 4.11 | |
β | Beta against Dow Jones | -2.01 | |
σ | Overall volatility | 0.04 | |
Ir | Information ratio | 0.17 |
Sunshine Biopharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Sunshine Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Sunshine Biopharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Sunshine Biopharma is way too risky over 90 days horizon | |
| Sunshine Biopharma has some characteristics of a very speculative penny stock | |
| Sunshine Biopharma appears to be risky and price may revert if volatility continues | |
| Sunshine Biopharma has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 24.09 M. Net Loss for the year was (4.51 M) with profit before overhead, payroll, taxes, and interest of 110.6 K. | |
| Sunshine Biopharma Warrant has accumulated about 40.56 M in cash with (8.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.8, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from news.google.com: Sunshine Biopharma stock hits 52-week low at 2.3 amid sharp decline - Investing.com Canada |
Sunshine Biopharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Sunshine Stock often depends not only on the future outlook of the current and potential Sunshine Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sunshine Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 12.2 K | |
| Cash And Short Term Investments | 16.3 M |
Sunshine Biopharma Technical Analysis
Sunshine Biopharma's future price can be derived by breaking down and analyzing its technical indicators over time. Sunshine Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Sunshine Biopharma Warrant. In general, you should focus on analyzing Sunshine Stock price patterns and their correlations with different microeconomic environments and drivers.
Sunshine Biopharma Predictive Forecast Models
Sunshine Biopharma's time-series forecasting models is one of many Sunshine Biopharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Sunshine Biopharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Sunshine Biopharma
Checking the ongoing alerts about Sunshine Biopharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Sunshine Biopharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Sunshine Biopharma is way too risky over 90 days horizon | |
| Sunshine Biopharma has some characteristics of a very speculative penny stock | |
| Sunshine Biopharma appears to be risky and price may revert if volatility continues | |
| Sunshine Biopharma has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 24.09 M. Net Loss for the year was (4.51 M) with profit before overhead, payroll, taxes, and interest of 110.6 K. | |
| Sunshine Biopharma Warrant has accumulated about 40.56 M in cash with (8.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.8, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from news.google.com: Sunshine Biopharma stock hits 52-week low at 2.3 amid sharp decline - Investing.com Canada |
Additional Tools for Sunshine Stock Analysis
When running Sunshine Biopharma's price analysis, check to measure Sunshine Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sunshine Biopharma is operating at the current time. Most of Sunshine Biopharma's value examination focuses on studying past and present price action to predict the probability of Sunshine Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sunshine Biopharma's price. Additionally, you may evaluate how the addition of Sunshine Biopharma to your portfolios can decrease your overall portfolio volatility.